Literature DB >> 18334249

Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example.

Cédric Laguri1, Fernando Arenzana-Seisdedos, Hugues Lortat-Jacob.   

Abstract

Chemokines are small proteins, promoting directional migration and activation of different cells through binding to specific receptors. Most chemokines also bind to heparan sulfate (HS), a family of complex and highly sulfated glycosaminoglycan (GAG) found at the cell surface and in the extracellular matrix. This class of molecules has recently emerged as critical regulators of many events involving cell response to the external environment. Binding to HS is thought to be functionally important. Current models suggested that HS ensures the correct positioning of chemokines within tissues and maintains haptotactic gradients of the proteins along cell surfaces, thus providing directional cues for migrating cells. On the chemokine surface, the GAG binding epitopes can be displayed on different areas, some of which overlap the receptor binding domain, while others are clearly separated. We review here some structural aspects of the interaction between GAGs or receptors and chemokines. In particular, we will address the case of CXCL12, a chemokine whose receptor binding site is distinct from the GAG binding site and whose different isoforms display different GAG binding abilities. This chemokine system thus offers an unprecedented opportunity to ascertain the importance of chemokine/GAG interaction in the regulation of cell migration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18334249     DOI: 10.1016/j.carres.2008.01.047

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  33 in total

1.  Essential role of immobilized chemokine CXCL12 in the regulation of the humoral immune response.

Authors:  Aleksandr Barinov; Lingjie Luo; Pamela Gasse; Vannary Meas-Yedid; Emmanuel Donnadieu; Fernando Arenzana-Seisdedos; Paulo Vieira
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

2.  Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses.

Authors:  Kerry S Campbell; Angel Porgador; Michael Brusilovsky; Moti Cordoba; Benyamin Rosental; Oren Hershkovitz; Mark D Andrake; Anna Pecherskaya; Margret B Einarson; Yan Zhou; Alex Braiman
Journal:  J Immunol       Date:  2013-10-14       Impact factor: 5.422

Review 3.  Chemokine signaling in development and disease.

Authors:  John Wang; Holger Knaut
Journal:  Development       Date:  2014-11       Impact factor: 6.868

4.  Chemical Tumor Biology of Heparan Sulfate Proteoglycans.

Authors:  Karthik Raman; Balagurunathan Kuberan
Journal:  Curr Chem Biol       Date:  2010-01-01

5.  Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans.

Authors:  India C Severin; Jean-Philippe Gaudry; Zoë Johnson; Andreas Kungl; Ariane Jansma; Bernd Gesslbauer; Barbara Mulloy; Christine Power; Amanda E I Proudfoot; Tracy Handel
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

6.  Glioma Cell Invasion is Significantly Enhanced in Composite Hydrogel Matrices Composed of Chondroitin 4- and 4,6-Sulfated Glycosaminoglycans.

Authors:  Meghan T Logun; Nicole S Bisel; Emily A Tanasse; Wujun Zhao; Bhagya Gunasekera; Leidong Mao; Lohitash Karumbaiah
Journal:  J Mater Chem B       Date:  2016-08-26       Impact factor: 6.331

7.  SDF-1α in glycan nanoparticles exhibits full activity and reduces pulmonary hypertension in rats.

Authors:  Tao Yin; Andrew R Bader; Tim K Hou; Bradley A Maron; Derrick D Kao; Ray Qian; Daniel S Kohane; Diane E Handy; Joseph Loscalzo; Ying-Yi Zhang
Journal:  Biomacromolecules       Date:  2013-10-18       Impact factor: 6.988

8.  Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions.

Authors:  Patricia Rueda; Adèle Richart; Alice Récalde; Pamela Gasse; José Vilar; Coralie Guérin; Hugues Lortat-Jacob; Paulo Vieira; Franoise Baleux; Fabrice Chretien; Fernando Arenzana-Seisdedos; Jean-Sébastien Silvestre
Journal:  Circulation       Date:  2012-10-03       Impact factor: 29.690

9.  64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4.

Authors:  Orit Jacobson; Ido D Weiss; Lawrence Szajek; Joshua M Farber; Dale O Kiesewetter
Journal:  Bioorg Med Chem       Date:  2009-01-15       Impact factor: 3.641

10.  Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

Authors:  Graeme O'Boyle; Paul Mellor; John A Kirby; Simi Ali
Journal:  FASEB J       Date:  2009-08-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.